TABLE 1

Parameters of [35S]GTPγS binding to membranes from CHO cells

EMAX is expressed as percentage of increase above basal binding, and concentrations of agonists producing EC50 are expressed as negative logarithms of [35S]GTPγS binding to membranes from CHO cells expressing M1 or M2 receptors, respectively. Data are means ± S.E.M. from four to six independent experiments performed in quadruplicates.

M1 M2
pEC50EMAX pEC50EMAX
% above basal % above basal
Without preincubation
Xanomeline 8.04 ± 0.01* 228 ± 9* N.E. N.E.
Carbachol 6.08 ± 0.01 179 ± 7 6.12 ± 0.05 187 ± 0.06
+ 3 nM xanomeline 5.97 ± 0.03* 179 ± 8 N.M. N.M.
+ 10 nM xanomeline 5.79 ± 0.04* 183 ± 7 6.01 ± 0.05 186 ± 0.06
+ 30 nM xanomeline 5.39 ± 0.01* 184 ± 8 5.89 ± 0.03* 185 ± 0.09
+ 100 nM xanomeline 5.02 ± 0.02* 184 ± 9 5.63 ± 0.02* 182 ± 0.08
+ 300 nM xanomeline N.M. N.M. 5.16 ± 0.05* 196 ± 0.09
With 60-min preincubation
Xanomeline 8.15 ± 0.04* 224 ± 6* 7.78 ± 0.03 75 ± 5*
Carbachol 6.08 ± 0.04 189 ± 6 6.12 ± 0.03 188 ± 6
+ 3 nM xanomeline 5.92 ± 0.04* 189 ± 7 N.M. N.M.
+ 10 nM xanomeline 5.68 ± 0.03* 189 ± 8 6.02 ± 0.01 191 ± 7
+ 30 nM xanomeline 5.32 ± 0.03* 195 ± 9 5.68 ± 0.02* 197 ± 8
+ 100 nM xanomeline 4.91 ± 0.03* 194 ± 11 5.28 ± 0.03* 190 ± 8
+ 300 nM xanomeline N.M. N.M. 4.97 ± 0.04* 194 ± 7
With 60-min preincubation followed by washing
Xanomeline 5.98 ± 0.03 208 ± 6* 5.81 ± 0.03* 62 ± 5*
Carbachol 6.07 ± 0.03 186 ± 6 6.06 ± 0.03 195 ± 6
+ 0.3 μM xanomeline 6.08 ± 0.04 189 ± 7 6.04 ± 0.04 190 ± 8
+ 1 μM xanomeline 6.18 ± 0.01 187 ± 9 6.07 ± 0.05 181 ± 9
+ 3 μM xanomeline 5.84 ± 0.05* 194 ± 8 6.01 ± 0.02 173 ± 7*
+ 10 μM xanomeline 5.42 ± 0.05* 178 ± 9 5.86 ± 0.01* 165 ± 7*
  • N.E., no effect; N.M., not measured.

  • * P < 0.05, significantly different from carbachol or carbachol alone by t test or ANOVA followed by Dunnett's test.